Perdih A - Search Results

1

The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents.

Vitorović-Todorović MD, Worek F, Perdih A, Bauk SĐ, Vujatović TB, Cvijetić IN. Vitorović-Todorović MD, et al. Among authors: perdih a. Chem Biol Interact. 2019 Aug 25;309:108714. doi: 10.1016/j.cbi.2019.06.027. Epub 2019 Jun 19. Chem Biol Interact. 2019. PMID: 31228470

2

Molecular recognition of acetylcholinesterase and its subnanomolar reversible inhibitor: a molecular simulations study.

Vitorović-Todorović M, Cvijetić I, Zloh M, Perdih A. Vitorović-Todorović M, et al. Among authors: perdih a. J Biomol Struct Dyn. 2022 Mar;40(4):1671-1691. doi: 10.1080/07391102.2020.1831960. Epub 2020 Oct 13. J Biomol Struct Dyn. 2022. PMID: 33047663

3

Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα.

Cvijetić IN, Herlah B, Marinković A, Perdih A, Bjelogrlić SK. Cvijetić IN, et al. Among authors: perdih a. Pharmaceuticals (Basel). 2023 Feb 23;16(3):341. doi: 10.3390/ph16030341. Pharmaceuticals (Basel). 2023. PMID: 36986441 Free PMC article.

4

Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study.

Sova M, Perdih A, Kotnik M, Kristan K, Rizner TL, Solmajer T, Gobec S. Sova M, et al. Among authors: perdih a. Bioorg Med Chem. 2006 Nov 15;14(22):7404-18. doi: 10.1016/j.bmc.2006.07.027. Epub 2006 Aug 7. Bioorg Med Chem. 2006. PMID: 16891119

5

Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase.

Perdih A, Bren U, Solmajer T. Perdih A, et al. J Mol Model. 2009 Aug;15(8):983-96. doi: 10.1007/s00894-009-0455-8. Epub 2009 Feb 6. J Mol Model. 2009. PMID: 19198900

6

Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.

Perdih A, Kovac A, Wolber G, Blanot D, Gobec S, Solmajer T. Perdih A, et al. Bioorg Med Chem Lett. 2009 May 15;19(10):2668-73. doi: 10.1016/j.bmcl.2009.03.141. Epub 2009 Apr 1. Bioorg Med Chem Lett. 2009. PMID: 19369074

7

In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B.

Brvar M, Perdih A, Oblak M, Masic LP, Solmajer T. Brvar M, et al. Among authors: perdih a. Bioorg Med Chem Lett. 2010 Feb 1;20(3):958-62. doi: 10.1016/j.bmcl.2009.12.060. Epub 2009 Dec 22. Bioorg Med Chem Lett. 2010. PMID: 20045642

8

Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment.

Minovski N, Perdih A, Solmajer T. Minovski N, et al. Among authors: perdih a. J Mol Model. 2012 May;18(5):1735-53. doi: 10.1007/s00894-011-1179-0. Epub 2011 Aug 12. J Mol Model. 2012. PMID: 21833830

9

In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.

Brvar M, Perdih A, Hodnik V, Renko M, Anderluh G, Jerala R, Solmajer T. Brvar M, et al. Among authors: perdih a. Bioorg Med Chem. 2012 Apr 15;20(8):2572-80. doi: 10.1016/j.bmc.2012.02.052. Epub 2012 Mar 3. Bioorg Med Chem. 2012. PMID: 22444877

10

Recent advances in the development of catalytic inhibitors of human DNA topoisomerase IIα as novel anticancer agents.

Pogorelčnik B, Perdih A, Solmajer T. Pogorelčnik B, et al. Among authors: perdih a. Curr Med Chem. 2013;20(5):694-709. doi: 10.2174/092986713804999402. Curr Med Chem. 2013. PMID: 23210851 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters